On April 18, 2022 FORUS Therapeutics Inc, a Canadian Life Sciences company specialized in developing and commercializing unique and differentiated oncology focused therapies reported to be participating and presenting at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2nd and 3rd at the Metro Toronto Convention Centre (Press release, FORUS Therapeutics, APR 18, 2022, View Source;utm_medium=rss&utm_campaign=forus-therapeutics-will-be-presenting-at-the-bloom-burton-co-healthcare-investor-conference-on-may-3rd-2022 [SID1234612447]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Kevin Leshuk, Founder, President and CEO of FORUS Therapeutics Inc, will present more about this dynamic and exciting new Canadian company on May 3rd, 3:30 pm and will be available for 1 on 1 meetings throughout the 2-day program.